Treatment of Actinic Keratoses with Photodynamic Therapy
Skin Cancer Care Specialists | December 6, 2016
An estimated 58 million people in America deal with actinic keratoses (AKs), precancerous skin lesions that have developed as a result of overexposure to ultraviolet (UV) rays. Common on the face, ears and scalp, these lesions can vary in size from a tiny pinhead to larger than a quarter. If you are looking for an effective treatment option for AKs, we’re pleased to offer you photodynamic therapy, one of the latest treatment options available for the condition.
What Are Actinic Keratoses and Where Do They Come from?
Ranging in size from a tiny pinhead to bigger than a quarter, AKs often look like rough, scaly patches of skin, ranging in color from skin‐toned to reddish‐brown. They’re most often found in sun exposed places that have been overexposed to UV rays.
Why Does Treating AKs Matter?
Up to 10 percent of AKs may develop into squamous cell carcinoma (SCC), which means that of 58 million people with AKs, up to 5.8 million could be headed for a skin cancer diagnosis. Early detection is key—and early detection is easiest through skin check examinations on a regular basis.
How Does Photodynamic Therapy Help?
One of the most effective treatment options for AKs today is photodynamic therapy. The Blu‐U Light photodynamic therapy uses a blue light to treat and kill premalignant cells and precancerous spots, effectively treating the lesions before they can grow. Its photosensitizer gets absorbed into the skin in order to target the deeper layers.
If you’re interested in learning more about photodynamic therapy or scheduling a
skin check examination, contact us today!